Cytovation Company Profile, Contacts & Intelligence
Cytovation Overview
Cytovation is a clinical stage immuno-oncology biotech developing first-in-class immunotherapies. CY-101, its lead asset, is a synthetic peptide engineered to selectively target tumor cells. CY-101 has a unique dual MoA applicable across solid tumors: (1) direct tumor-specific membrane lysis and in-situ vaccination, combined with (2) immune activation through inhibition of the β-catenin pathway. Building on strong FIH clinical data, Cytovation is advancing CY-101 to POC/pivotal clinical development with a focus on b-catenin-driven cancers.
- Headquarters
- Bergen, Vestland, No
- Website
- cytovation.com
- Industry
- Biotechnology Research
- Founded
- 2015
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Cytovation Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Cytovation People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Cytovation Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to Cytovation
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| LETI Pharma | Pharmaceutical Manufacturing | 593 | View company |
| Nykode Therapeutics | Biotechnology Research | 90 | View company |
| Arctic Bioscience | Biotechnology Research | 44 | View company |
| Lytix Biopharma | Biotechnology | 23 | View company |
| BerGenBio ASA | Biotechnology Research | 20 | View company |
| Thor Medical ASA | Biotechnology Research | 19 | View company |
| AlgiPharma AS | Biotechnology Research | 12 | View company |
| Nexkin medical | Medical Equipment Manufacturing | 11 | View company |
| VB Devices | Medical Device | 10 | View company |
| Ultimovacs ASA | Biotechnology | Not listed | View company |